HYQVIA
HYQVIA
Approved
DIN Number
02524376
Drug Class
Human
Market Date
Nov 7, 2023
Company
HC
takeda canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02524376
AIG Number0263359001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J06BA01 IMMUNOGLOBULINS, NORMAL HUMAN, FOR EXTRAVASC. ADM
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification80:04.00
Health Canada Classification
ACTIVE INGREDIENTS (2)
HYALURONIDASE (HUMAN RECOMBINANT)Active
Strength: 400 UNIT / 2.5 ML
Monograph: HYALURONIDASE (HUMAN RECOMBINANT)
IMMUNOGLOBULIN (HUMAN)Active
Strength: 5 G / 50 ML
Monograph: IMMUNOGLOBULIN (HUMAN)